GlassScriptPhysician profile
Tal R Raphaeli
NPI 1609910009
$5,549.41
in general payments reported to CMS, 2019-2025
18 companies · $92.35 in 2025
The $92.35 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,957 · 2020: $167 · 2021: $89.32 · 2022: $471 · 2023: $409 · 2024: $2,364 · 2025: $92.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,477 · Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,476.81 |
| Food and Beverage | $1,388.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,862.38 | 2022-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $1,840.52 | 2019 | |
| Medtronic, INC. | $511.52 | 2022-2024 | Interstim, Endo Gia Ultra |
| Ethicon US, LLC | $344.14 | 2021-2023 | Harmonic |
| Tela Bio, INC. | $270.16 | 2020-2024 | Ovitex 2s |
| Baxter Healthcare | $225.94 | 2021-2024 | Perclot, Tisseel |
| Biosense Webster, INC. | $162.88 | 2022-2025 | Octaray Mapping Catheter, Qdot Micro |
| Medtronic USA, INC. | $116.69 | 2019 | |
| Mimedx Group, INC. | $33.12 | 2024 | |
| Innocoll Pharmaceuticals Limited | $29.27 | 2022 | |
| Boston Scientific Corporation | $28.15 | 2025 | Resolution 360 Clip |
| Davol INC. | $26.45 | 2023 | Phasix Mesh |
| Thd America, INC. | $20.41 | 2022-2023 | |
| Coloplast Corp | $16.64 | 2023 | Sensura Mio |
| Kerecis Limited | $15.88 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $15.48 | 2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $14.90 | 2025 | Exparel |
| Smith+Nephew, INC. | $14.88 | 2024 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tal Raphaeli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.